top of page



Competition among Researchers across Japan and South East Asia

Join us Online on August 2

6:30 PM SGT| 7:30 PM Japan| 4:00 pm India| 6:30 AM New York| 11:30 AM London


Celebrating Excellence: Top 3 Presentations from Each Category

2 Keynote Speakers

2 Sessions

Result Announcement and Award Ceremony

DRPI, short for Dissolution Research Presentations International, is back with its fourth edition, and this time, it is a global competition between researchers from five different regions of the world. The regions include India, Japan & South East Asia (JSEA), the USA, Australia, and the United Kingdom. The competition will have regional competitions, followed by global semifinals and finals online in September. The Japan & Southeast Asia (JSEA) chapter of DRPI was established in 2023 and is chaired by Professor Matthias G. Wacker from the National University of Singapore. DRPI-JSEA caters to the dynamic research landscape in the region and invites submissions from countries all over Asia. The competition is co-organised by the Department of Pharmacy, NUS-AAPS Student Chapter in partnership with Pharma Test, Sotax, Gaia Science, and Malvern Panalytical.

Invitation for Abstract Submissions

We warmly invite abstract submissions from researchers across Japan and South East Asia for the above event. Abstracts are welcome from young early level researchers (Undergraduate, Pharm.D., M.Sc.) to research professionals (PhD, Postdoc, Industry) across academia and industry.

Abstracts would be accepted from May 08 till Jun 09, 2023 under two categories:

  1. Category 1a: Pharm.D. | Pharm. Sci. | M.Sc.
    Category 1b: UROPS FYP | Sci Phi [Only for DRPI-JSEA 2023 regional competition]

  2. Category 2: PhD | Postdoc | Industry


in the areas of research related to:

  1. Dissolution & Solubility Modulation

  2. In vitro Release/Permeation Studies of Conventional & Novel Dosage Forms, including Herbals, Nutraceuticals & Cosmeceuticals

  3. Pharmacokinetics & IVIVC Studies

  4. Modified Dissolution Equipment & Methodologies, including Biorelevant Media & Automation

  5. Computational Tools, PBPK Modelling

Why should you participate in DRPI-JSEA?

  1. International Exposure: Put your hours of hard work in an international stage and let the world know about your research excellence. 

  2. Recognition and Networking: Gain profile recognition amongst acclaimed scientists and have excellent networking opportunities.

  3. Present to Global Audience: Winners of DRPI-JSEA qualify for DRPI-World and compete with other regional champions.

  4. Grab Attractive Cash Prize and Certificates: Top 3 winners in each category of DRPI-JSEA will be awarded with cash prize and certificates.

Key Timelines

Guidelines for preparing abstract

Please arrange abstract body text under the following headings and in the order shown:

Background and Rationale: Should be as brief as possible and should provide background information to understand the research work to be presented by you.

Conclusions: Should highlight the significance of your results.

References: All references, including URLs, must be numbered consecutively, in the order in which they are cited in the text. Use the style of citation and references as given in the sample model abstract provided. Restrict to a maximum of 3 references.

Footnotes: Use of footnotes is permitted but should be limited as much as possible.
Restrict abstract body text to A4 size ­one page document with a maximum of 250 words. Abstracts that run into 2 or more pages would be rejected.

You may refer to the modal abstract

Scientific Committee Members

Dr. Chin Chiat Lee (JSEA guest judge)


A/P Celine Liew

Monash University Malaysia

Dr. Linda Hong (JSEA guest judge)

National University of Singapore

A/P Paul Heng

National University of Singapore

A/P Atsushi Kambayashi

Tokyo University of Science

A/P Matthias Wacker

National University of Singapore

Accepted Abstracts

Early-stage Researchers: 

  • Drug release from a biodegradable Chemo-Radioembolization agent loaded with Sm-153 Radionuclide and Doxorubicin

  • Particle Size and In Vitro Correlation of Transdermal Patch Development Based on Nanophytosomes of Leaf Ethanol Extract of Kenikir (Cosmos caudatus) as Prevention Efforts Complication Dislipid

  • Developing and optimising an in vitro gel-based release assay for subcutaneously administered insulins with the USP dissolution apparatus IV

  • Development of Autoclave Stable Cationic Polymer Eluting Antifungal Contact Lenses for Fusarium Keratitis

Late-stage Researchers:

  • Ageing as a Stabilising Process for Sustainable Dissolution Enhancement in a Carrier Tailored Atovaquone Electrospun

  • Mechanistic exploration of the drug release properties of advanced semisolid dosage forms using the dispersion releaser

  • Role of Cell Interactions of PLG Nanoparticles in the Drug Delivery Lifecycle

  • Understanding the Structure-Release Relationships of Sepineo

  • Use of PBPK modelling for predicting absorption and systemic exposure of compounds with complex absorption kinetics: a case study on stevioside and its metabolites

Registration anchor
Registration Form
How did you find about DRPI-JSEA?

Thank you for signing up. Your registration was successful.

Organizers and Partners

MicrosoftTeams-image (2).png


MicrosoftTeams-image (4).png
MicrosoftTeams-image (6).png
bottom of page